7th May 2025
SMK: JPJ
ISIN: GB00BLH1QT30
SAMARKAND GROUP
(“SMK” or “The Company”)
Shares now trading on JP Jenkins
London, UK, 7th May 2025 – Samarkand Group (SMK:JPJ), today announces its shares have
been admitted to trade on JP Jenkins share dealing platform. The Company’s registered
address is Unit 13 Tonbridge Trade Park, Ingot Way, Tonbridge, England, TN9 1GN and
company number is 13127277.
Samarkand is a consumer brand owner operating a scale up platform for meaningful different,
high growth, high potential health and healing brands. Owned brands include Napiers the
Herbalists, Scotland’s oldest natural herbal apothecary brand and Zita West, a leading
specialist supplement line for fertility and reproductive health as well as Natures Greatest
Secret a leading colloidal silver-based health and healing brand. Brands are marketed on an
omnichannel basis with strong DTC and social commerce capabilities. In addition to specialist
brand and marketing teams, the Company’s brands benefit from shared operational resources
including shared warehousing and logistics and pick pack ship services from the Company’s
own warehouse and in house manufacturing from the Company’s own specialist production
facilities.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell equity on a matched bargain
basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of
Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades
will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
Trades can be conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares as well as the transaction history, will be available
on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Samarkand Group
Investor Relations
Tel. 020 3740 3933
Email: info@samarkand.global
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
